Case Report

The Hepatic Phase of Fascioliasis Complicated with Liver Bleeding: Presentation of Three Cases

Abstract

Bleeding is a very rare complication of Fasciola species (F. hepatica or F. gigantica) infection. We present here three cases of subcapsular liver bleeding caused by the hepatic phase of Fasciola spp. infection in patients, two of whom were women, aged 22, 66, and 84 years in Diyarbakir Province, southeastern Turkey. They had symptoms of right upper quadrant pain (n = 3), nausea (n = 1), and vomiting (n = 2) for periods ranging from 6 hours to 15 days. All patients with clinical presentations ranging from moderate abdominal pain to hypovolemic shock and ischemic hepatitis were improved with supportive treatment without the need for surgery. They showed complete clinical and laboratory recovery after triclabendazole administration in their follow-up. In conclusion, Fasciola spp. infection should be considered in the etiology of bleeding from liver disease.

1. Infantes LRR, Yataco GAP, Ortiz-Martínez Y, et al. The global prevalence of human fascioliasis: a systematic review and meta-analysis. Ther Adv Infect Dis. 2023; 10:20499361231185413.
2. Kaya M, Beştaş R, Çetin S. Clinical presentation and management of Fasciola hepatica infection: single-center experience. World J Gastroenterol. 2011; 17:4899-4904.
3. Mas-Coma S, Valero MA, Bargues MD. Fascioliasis. Adv Exp Med Biol. 2019:1154:71-103.
4. Leon M, Alave J, Alvarado R, Gotuzzo E, Terashima A, Seas C. A 52-year-old woman with a subcapsular liver hematoma. Clin Infect Dis. 2011; 52:1137, 1195-6.
5. Kim SB, Kim TN, Kim KH. Fascioliasis: A rare cause of hepatic pseudoaneurysmal rupture. J Gastroenterol Hepatol. 2015;30:4.
6. Zhou L, Luo L, You C, Wang B, Xu J, Liao L, Hui X, Cai B. Multiple brain hemorrhages and hematomas associated with ectopic fascioliasis in brain and eye. Surg Neurol. 2008;69: 516– 521.
7. El-Morshedy H, Farghaly A, Sharaf S, Abou-Basha L, Barakat R. Triclabendazole in the treatment of human fascioliasis: a community-based study. East Mediterr Health J. 1999;5(5):888-94.
8. Çiçek M, Yalçın K, Bilden A, Çakır F, Akpolat N. Evaluation of the seroprevalence and the demographic and clinical findings of fascioliasis patients in the Dicle River Basin in Turkey: a nine-year experience at a university hospital. Eur Rev Med Pharmacol Sci. 2023;27(22):10831-10838.
9. Mohammed-Ghalehbin B, Chinifroush-Asl MM, Ramzi F. Extra-hepatic fascioliasis with peritoneal malignancy tumor feature. J Parasit Dis. 2012; 36:78-80.
10. Henrion J. Hypoxic hepatitis. Liver Int. 2012; 32:1039-1052.
11. Fuhrmann V, Jager B, Zubkova A, Drolz A. Hypoxic hepatitis-epidemiology, pathophysiology and clinical management. Wien Klin Wochenschr. 2010; 122:129-139.
12. Drolz A, Horvatists T, Roedl K, Fuhrmann V. Shock liver and cholestatic liver in critically ill patients. Med Klin Intensivmed Notfmed. 2014; 109:228-234.
13. Tapper EB, Sengupta N, Bonder A. The incidence and outcomes of ischemic hepatitis: A systematic review with meta-analysis. Am J Med. 2015; 128:1314-1321.
Files
IssueVol 19 No 2 (2024) QRcode
SectionCase Report(s)
DOI https://doi.org/10.18502/ijpa.v19i2.15863
Keywords
Fasciola hepatica Hemorrhage Liver disease Shock
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Uçmak F, Kaya M. The Hepatic Phase of Fascioliasis Complicated with Liver Bleeding: Presentation of Three Cases. Iran J Parasitol. 2024;19(2):267-272.